Evernoa Base allows to measure the Fraction of Exhaled nitric oxide (FeNO) present in human breath. This biomarker provides in a minimally invasive, fast and simple way relevant information about airway inflammation. This information is useful in the diagnosis and monitoring of inflammatory respiratory diseases, such as asthma.